InfuSystem Holdings (INFU) Return on Invested Capital (2011 - 2022)
InfuSystem Holdings (INFU) posted Return on Invested Capital of 0.03% for Q4 2022, up 104.23% on a QoQ basis from 0.02% in Q3 2022, and up 3.0% year-over-year from 0.03% in Q4 2021.
InfuSystem Holdings (INFU) Return on Invested Capital (2011 - 2022) Analysis & Trends
InfuSystem Holdings' Return on Invested Capital history runs 12 years deep, the most recent figure standing at 0.03% for Q4 2022.
- Quarterly Return on Invested Capital rose 3.0% year-over-year to 0.03% in Q4 2022, while the trailing twelve-month figure through Dec 2022 was 0.03% (up 3.0% YoY) and the FY2021 annual result came in at 0.01%, down 2.0% from the prior year.
- Return on Invested Capital was 0.03% for Q4 2022 at InfuSystem Holdings, up from 0.02% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.03% in Q4 2022 and bottomed at 0.07% in Q1 2022.
- A 5-year average of 0.0% and a median of 0.0% in 2020 frame the typical range for Return on Invested Capital.
- Peak annual rise in Return on Invested Capital reached 3 bps in 2022, while the deepest fall reached 7 bps in 2022.
- InfuSystem Holdings' Return on Invested Capital stood at 0.0% in 2018, then soared by 317 bps to 0.0% in 2019, then surged by 412 bps to 0.01% in 2020, then declined by 23 bps to 0.01% in 2021, then jumped by 570 bps to 0.03% in 2022.
- Business Quant data shows INFU's Return on Invested Capital at 0.03% in Q4 2022, 0.02% in Q3 2022, and 0.01% in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.01% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.01% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.01% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.00% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.00% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 0.03% |
| Sep 30, 2022 | 0.02% |
| Jun 30, 2022 | 0.01% |
| Mar 31, 2022 | -0.07% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | 0.02% |
| Jun 30, 2021 | 0.01% |
| Mar 31, 2021 | 0.01% |
| Dec 31, 2020 | 0.01% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 0.00% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 0.00% |
| Sep 30, 2018 | -0.01% |
| Jun 30, 2018 | 0.00% |
| Mar 31, 2018 | 0.00% |